Approved in May 2019, granted to FoldRx, a subsidiary of Pfizer.
New Drug Review
Indicated as part of a three-drug oral combination.
Cariprazine demonstrated greater improvement on the MADRS.
First oral drug for advanced or metastatic bladder cancer.
The first drug approved to specifically treat post-partum depression.
Both responder and remitter patients experienced a statistically significant longer time to relapse with esketamine compared to the placebo
What you need to know about the serotonin-4 receptor agonist approved for adult patients.
Ongoing valsartan shortages due to recalls prompt FDA prioritization.
Sublingual form approved for short-term use.